[Bacteriological and pharmacokinetic properties of new oral cephalosporin compounds].
D001419:Bacteria / Q000187:drug effects*; D002511:Cephalosporins / Q000032:analysis / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D003864:Depression, Chemical; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D005779:Immunodiffusion; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects
D002511:Cephalosporins
Bakteriologische und pharmakokinetische Eigenschaften neuer oraler Cephalosporin-Verbindungen.